PRIVACY STATEMENT

The following statement explains Cynosure’s policy regarding any personal information supplied to Cynosure when you visit this Site.
Cynosure recognizes that visitors to this Site and with whom we conduct business value their privacy. Often, however, the collection of personal information is necessary and desirable both for the visitor and Cynosure. Thus, in some circumstances Cynosure may request personal information from you, like your name, e-mail address, company name, title, address and/or telephone number. Your response to these inquiries is strictly voluntary. Once submitted, Cynosure may use this information to customize your experience on this site and for other business purposes, such as sending you information about Cynosure and Cynosure’s products.  Cynosure will not sell, rent, or share your information with any other organization.
In general, you can visit our Site without divulging any personal information. Certain areas, however, require specific information and may not be available to visitors who choose not to provide such information.

Cynosure automatically collects domain information and pages accessed from all visitors to this Site as part of its on-going administration of this Site. This data helps Cynosure understand more about the types of visitors accessing this Site, how often they visit and what parts of the Site they visit most often. Cynosure may then use this information to modify and improve the Site.
Cynosure may modify or update this Privacy Statement at any time without notice.

TERMINATION OF USE

Cynosure may, in its sole discretion, terminate or suspend this Site and/or the Provider Locator or User’s access to and use of this Site and/or the Provider Locator without notice and for any reason, including for violation of these Terms & Conditions or for other conduct which Cynosure, in its sole discretion, believes is unlawful, unauthorized, or harmful to others. In the event of termination, User will no longer be authorized to access the Site, and Cynosure will use any means possible to enforce this termination.

COMPLETE AGREEMENT/SURVIVAL

User agrees that these Terms & Conditions supersede any and all agreements, either oral or written, between the parties hereto with respect to User’s use of this Site and the Provider Locator. THE TERMS & CONDITIONS SET FORTH HEREIN FOR USE OF PROVIDER LOCATOR, PATENT, COPYRIGHT, TRADEMARK, DISCLAIMER, LIMITIATION OF LIABILITY, APPLICABLE LAW, COMPLIANCE WITH APPLICABLE LAWS AND EXPORT CONTROL LAWS, JURISDICTION AND CHOICE OF LAW, INDEMNIFICATION, DISCLAIMER ABOUT THIRD PARTY PRODUCTS, LINKS TO THIRD PARTY WEBSITES, GENERAL, PRIVACY STATEMENT,  TERMINATION OF USE, COMPLETE AGREEMENT/SURVIVAL, “SAFE HARBOR” STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT shall survive any termination or expiration of these Terms & Conditions.
“SAFE HARBOR” STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT

With the exception of the historical information contained in Cynosure’s web site, the matters described in this Site contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the Company’s current expectations, plans, intentions, beliefs or predictions. These forward-looking statements are neither promises nor guarantees, but involve risk and uncertainties that may individually or mutually impact the matters stated on this Site, and cause actual results, events and performances to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products and additional applications, factors affecting the Company’s future income and/or other factors, which are detailed from time to time in the Company’s SEC reports, including its annual reports on Form 10-K and the Company’s quarterly reports on Form 10-Q which are accessible on this Site under the Investor Relations tab. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date first made or to reflect the occurrence of unanticipated events.

Thank you for your cooperation. We hope the User finds the Site helpful and convenient to use.

VIEW TERMS & CONDITIONS